Clin2
NCT07719088Likely a fitNot yet recruiting

Psilocybin, aging, and purpose in life study

AgingLongevityBiomarkers of Aging

Treatments studied

This trial tests whether psilocybin affects biological signs of aging and how much purpose you feel in life. If you are a healthy adult, you may qualify.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
50 people
Ages
60 years to 80 years
Study type
Interventional

Who can take part

  • You speak English and can agree to the study schedule.
  • You are in good medical health with no major health issues.
  • You do not have a psychiatric or medical condition that could make the study unsafe.
  • Your heart test (ECG) is normal and does not show risks.
  • You can safely stop taking any medications that might interfere with the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06367738Recruiting· Phase 1
Psilocybin and brain changes in healthy older adults

This study looks at how a single dose of psilocybin (the active ingredient in magic mushrooms) affects brain structure in healthy older adults. You'll receive the drug in a safe setting and have brain scans before and after to see if it promotes positive changes.

Berkeley, California
NCT07202403Enrolling by invitation
Dietary supplements and aging therapy trial

This trial tests dietary supplements and other treatments aimed at slowing the effects of aging. It is looking for generally healthy adults who are not taking immune-altering medications or other conflicting therapies.

New York, New York
NCT07516405Recruiting· Phase 1
Psilocybin Safety Study in Older Adults

This research tests whether psilocybin (a psychoactive compound from certain mushrooms) is safe and well-tolerated in healthy people aged 65–85. Researchers want to understand how older adults respond to this substance and whether it could be useful for future treatments.

San Francisco, California
NCT07386730Recruiting· Phase 1
Psychedelic therapy study for older adults with low well-being

This study tests if a single dose of psilocybin (a psychedelic) or dextromethorphan (a cough suppressant) can improve well-being in healthy older adults who feel their well-being is below average. It aims to understand how these drugs might help boost mood and life satisfaction.

San Francisco, California
NCT07079852Not yet recruiting· Phase 1/Phase 2
Psilocybin and its effects on memory and brain function

This trial tests how psilocybin, a psychedelic substance, affects your thinking, memory, and brain activity. Researchers want to understand these effects in healthy adults who have used psychedelics before.

Austin, Texas
NCT07732166Recruiting· Early Phase 1
Psilocybin and Self-Awareness Study

This trial tests whether a single dose of psilocybin (a psychedelic substance) can change self-awareness in healthy adults. It aims to understand how this substance affects the brain, which might lead to new mental health treatments.

Rio de Janeiro, Rio de Janeiro

Hear when a new Longevity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.